N
Nautilus
Biotech & Life Sciences · San Carlos, United States · Founded 2016 · Public via SPAC 2021
Delivering a high-throughput, low-cost platform for analyzing and quantifying the human proteome MoreLess
Nautilus Biotechnology operates in the biotechnology sector, focusing on proteomics, which is the large-scale study of proteins. The company has developed an advanced platform designed to accelerate the drug development process by providing researchers with deep insights into the roles of drug targets in health and disease. This platform aims to make it easier to prioritize drug targets with high potential for clinical success, thereby reducing inefficiencies and costs associated with traditional drug discovery methods. Nautilus Biotechnology serves pharmaceutical companies, research institutions, and biotech firms, offering them a tool to enhance their research capabilities and improve clinical outcomes. The business model is primarily B2B (business-to-business), generating revenue through the sale of its proteomics platform and related services. By unlocking the proteome, Nautilus aims to fuel breakthroughs in basic biology, medicine, and biotechnology, ultimately impacting global health positively.
Keywords: proteomics, drug discovery, biotechnology, clinical success, pharmaceutical, research, platform, health, innovation, efficiency.
Talent graph
Nautilus's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Nautilus has talent and traffic
team presence
across markets
Patent intelligence
$17M patent portfolio · 19 active families
Where Nautilus concentrates vs peers
Each axis is a top-10 topic across Nautilus and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Nautilus
An AI-synthesized read of the highest-engagement posts about Nautilus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nautilus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.